Spanish Pompe registry: Baseline characteristics of first 49 patients with adult onset of Pompe disease

被引:10
作者
Alonso-Perez, Jorge [1 ]
Segovia, Sonia [2 ]
Dominguez-Gonzalez, Cristina [2 ,3 ]
Olive, Montse [4 ,5 ]
Mendoza Grimon, Maria Dolores [6 ]
Fernandez-Torron, Roberto [7 ]
Lopez de Munain, Adolfo [7 ]
Luis Munoz-Blanco, Jose [8 ]
Ramos-Fransi, Alba [9 ]
Almendrote, Miriam [9 ]
Illa, Isabel [1 ,2 ]
Diaz-Manera, Jordi [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Unidad Patol Neuromuscular, Barcelona, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain
[3] Hosp Univ 12 Octubre, Inst Invest I 12, Unidad Neuromuscular, Serv Neurol, Madrid, Spain
[4] Hosp Univ Bellvitge, Serv Anat Patol Neuropatol, Barcelona, Spain
[5] Hosp Univ Bellvitge, Unidad Patol Neuromuscular, Barcelona, Spain
[6] Hosp Univ Gran Canaria Dr Negrin, Serv Neurol, Gran Canaria, Spain
[7] Hosp Donosti, Serv Neurol, San Sebastian, Spain
[8] Hosp Gregorio Maranon, Serv Neurol, Madrid, Spain
[9] Hosp Badalona Germans Trias & Pujol, Serv Neurol, Badalona, Spain
来源
MEDICINA CLINICA | 2020年 / 154卷 / 03期
关键词
Pompe disease; Glycogenosis type II; Patient registry; Enzyme replacement therapy; Spanish Registry of Neuromuscular; Diseases; CLINICAL-FEATURES; PHENOTYPE; FREQUENCY; DIAGNOSIS; ALPHA;
D O I
10.1016/j.medcli.2019.03.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Pompe disease is a rare autosomal recessive disorder produced by a deficiency of acid maltase. This deficit produces an accumulation of glycogen in tissues. Clinically it is mainly characterized by limb girdle and respiratory muscle weakness. In 2013, we developed the Spanish Pompe Registry. The objective of this article was to analyse the characteristics of the first 49 patients and disclose the existence of this registry within the medical community. Material and methods: An observational retrospective study was undertaken. We analysed the 49 patients included in the Spanish Registry of Pompe Disease from May 2013 to October 2018. Results: Patients were visited at 7 different Spanish hospitals. Twenty-six patients were women and 23 were men. The average age at the time of the analysis was 47.2 years. Ten patients were asymptomatic. The mean age of onset of symptoms was 29, and low limb girdle weakness was the most frequent initial symptom. Of the patients, 49% had respiratory involvement, and 70.8% of them required non-invasive mechanical ventilation. The most common mutation found was IVS1-13T>G in 85.3% of the patients. All symptomatic patients received treatment with ERT. Conclusions: This registry allows us to know the clinical and genetic characteristics of adult patients with Pompe disease in Spain. Moreover, it can be the basis for future studies of natural history to understand the impact of ERT in the course of the disease. (C) 2019 Published by Elsevier Espana, S.L.U.
引用
收藏
页码:80 / 85
页数:6
相关论文
共 32 条
[11]   A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease [J].
Kishnani, Priya S. ;
Hwu, Wuh-Liang ;
Mandel, Hanna ;
Nicolino, Marc ;
Yong, Florence ;
Corzo, Deyanira .
JOURNAL OF PEDIATRICS, 2006, 148 (05) :671-676
[12]   Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants [J].
Kishnani, Priya S. ;
Goldenberg, Paula C. ;
DeArmey, Stephanie L. ;
Heller, James ;
Benjamin, Danny ;
Young, Sarah ;
Bali, Deeksha ;
Smith, Sue Ann ;
Li, Jennifer S. ;
Mandel, Hanna ;
Koeberl, Dwight ;
Rosenberg, Amy ;
Chen, Y. -T .
MOLECULAR GENETICS AND METABOLISM, 2010, 99 (01) :26-33
[13]   Pompe Disease: From Basic Science to Therapy [J].
Kohler, Lara ;
Puertollano, Rosa ;
Raben, Nina .
NEUROTHERAPEUTICS, 2018, 15 (04) :928-942
[14]   Long-term benefit of enzyme replacement therapy in Pompe disease A 5-year prospective study [J].
Kuperus, Esther ;
Kruijshaar, Michelle E. ;
Wens, Stephan C. A. ;
de Vries, Juna M. ;
Favejee, Marein M. ;
van der Meijden, Jan C. ;
Rizopoulos, Dimitris ;
Brusse, Esther ;
van Doorn, Pieter A. ;
van der Ploeg, Ans T. ;
van der Beek, Nadine A. M. E. .
NEUROLOGY, 2017, 89 (23) :2365-2373
[15]   The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease [J].
Laforet, P. ;
Laloui, K. ;
Granger, B. ;
Hamroun, D. ;
Taouagh, N. ;
Hogrel, J. -Y. ;
Orlikowski, D. ;
Bouhour, F. ;
Lacour, A. ;
Salort-Campana, E. ;
Penisson-Besnier, I. ;
Sacconi, S. ;
Zagnoli, F. ;
Chapon, F. ;
Eymard, B. ;
Desnuelle, C. ;
Pouget, J. .
REVUE NEUROLOGIQUE, 2013, 169 (8-9) :595-602
[16]  
Martiniuk F, 1998, AM J MED GENET, V79, P69, DOI 10.1002/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO
[17]  
2-K
[18]   Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy [J].
Parini, Rossella ;
De Lorenzo, Paola ;
Dardis, Andrea ;
Burlina, Alberto ;
Cassio, Alessandra ;
Cavarzere, Paolo ;
Concolino, Daniela ;
Della Casa, Roberto ;
Deodato, Federica ;
Donati, Maria Alice ;
Fiumara, Agata ;
Gasperini, Serena ;
Menni, Francesca ;
Pagliardini, Veronica ;
Sacchini, Michele ;
Spada, Marco ;
Taurisano, Roberta ;
Valsecchi, Maria Grazia ;
Di Rocco, Maja ;
Bembi, Bruno .
ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
[19]   Prevalence of lysosomal storage diseases in Portugal [J].
Pinto, R ;
Caseiro, C ;
Lemos, M ;
Lopes, L ;
Fontes, A ;
Ribeiro, H ;
Pinto, E ;
Silva, E ;
Rocha, S ;
Marcao, A ;
Ribeiro, I ;
Lacerda, C ;
Ribeiro, G ;
Amaral, O ;
Miranda, MCS .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (02) :87-92
[20]   Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T &gt; G "late-onset" GAA variant [J].
Rairikar, Mugdha V. ;
Case, Laura E. ;
Bailey, Lauren A. ;
Kazi, Zoheb B. ;
Desai, Ankit K. ;
Berrier, Kathryn L. ;
Coats, Julie ;
Gandy, Rachel ;
Quinones, Rebecca ;
Kishnani, Priya S. .
MOLECULAR GENETICS AND METABOLISM, 2017, 122 (03) :99-107